author-photo

Carlos A. Zarate

National Institutes of Health

494

Papers

23767

Citations

Citation Trend

Filter By

Papers (494) Sort By

Journal Conference Others

Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.

2021 The Canadian Journal of Psychiatry
- Carlos A. Zarate
Show All
- Source
- Cite
- Save
Citations (4)
The Right Hemisphere Is Responsible for the Greatest Differences in Human Brain Response to High-Arousing Emotional versus Neutral Stimuli: A MEG Study.

2021 Brain Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of the safety, tolerability and pharmacokinetic profiles of TP0473292 (TS-161), a prodrug of a novel orthosteric mGlu2/3 receptor antagonist TP0178894, in healthy subjects and its antidepressant-like effects in rodents.

2021 The International Journal of Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road.

2021 Drug Discovery Today
Show All
- Source
- Cite
- Save
Citations (3)
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.

2021 CNS Drugs
Show All
- Source
- Cite
- Save
Citations (7)
Glutamate modulators and beyond: A neuroscience revolution in the making.

2021 European Neuropsychopharmacology
- Carlos A. Zarate
Show All
- Source
- Cite
- Save
Citations (0)
Reply to Drs. Hart and Cadet: we agree-the challenges of increasing equity, diversity and inclusion include societal issues and actions now are vital.

2021 Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (0)
The Dynamic Relationship Between Alpha and Beta Power and Next-Day Suicidal Ideation in Individuals With Treatment-Resistant Depression

2021
Show All
- Source
- Cite
- Save
Citations (0)
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.

2021 Pharmacological Reviews
Show All
- Source
- Cite
- Save
Citations (10)
Key considerations in the pharmacological management of treatment-resistant depression.

2021 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (1)